We use analytics cookies to give us insight into how our website is being used. Learn more in our cookie notice I Accept +
Bleepa achieves CE Mark - Raising the bar for medical communication platforms

+44 (0) 20 3997 7634 | sales@fbkmed.com

The use of Quantitative Textural Analysis imaging biomarkers to predict response to temsirolimus treatment in advanced HCC subjects.

The use of Quantitative Textural Analysis imaging biomarkers to predict response to temsirolimus treatment in advanced HCC subjects.

09/11/14
Back To News +

Latest Articles

Year end trading update

16/06/22

Bleepa Cadran Feedback Medical Feedback PLC

Bleepa wins two NHS contract awards

12/04/22

Bleepa Feedback Medical Feedback PLC

Bleepa TB screening pilot now live in Odisha

31/03/22

Bleepa Feedback Medical Feedback PLC